@article{0e810dcb9e84415f898418e3a4189be4,
title = "Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients",
abstract = "The mortality rate for transurethral prostatectomy was 0.2 per cent in 3,885 patients reviewed retrospectively. The immediate postoperative morbidity rate was 18 per cent. Increased morbidity was found in patients with a resection time of more than 90 minutes, gland size of more than 45 gm., acute urinary retention and patient age greater than 80 years, and in the black population. Of the patients 77 per cent had significant pre-existing medical problems. Operative mortality, significant morbidity and hospital stay were reduced in comparison to studies done 15 and 30 years ago.",
author = "Mebust, {W. K.} and Holtgrewe, {H. L.} and Cockett, {A. T.K.} and Peters, {P. C.}",
note = "Funding Information: There were 13 participants asked to review their most current 300 consecutive cases of transurethral prostatectomy. Surgery was performed at each institution by the participant or his associates. All case material was submitted by October 1, 1987 to the American Urological Association Office of Education for computer analysis. The participants were selected taking into consideration their geographic location and type of practice. Some were in a small group community practice and others were in. a large multidisciplinary group practice, including academic centers. The investigators evaluated 250 parameters for each case. The number of cases of transurethral prostatectomy per year from 1978 to 1987 is shown'~in figure 1. Major categories of specific information included demographic data, indications for transurethral resection of the prostate, medical history, preoperative evaluation, operative management, intraopera-tive complications, immediate postoperative complications, postoperative management and long-term complications. Of the transurethral prostatectomies 78 per cent were performed between 1984 and 1987. Followup data were obtained in 92 per cent of the patients, with 85 per cent being seen Accepted for publication July 11, 1988. Supported in part through a grant from ICI Pharma. * Members of the Writing Committee: W. K. Mebust, University of Kansas Medical Center, Kansas City, Kansas; H. L. Holtgrewe, Annapolis, Maryland; A. T. K. Cockett, University of Rochester Medical Center, Rochester, New York; P.C. Peters, University of Texas{"} Health Science Center, Dallas, Texas; A. J. Bueschen, University of Alabama Medical Center, Birmingham, Alabama; C. E. Carlton, Jr., Baylor College of Medicine, Houston, Texas; S. E. Denton, St. Joseph Hospital, Phoenix, Arizona; R.P. Gibbons, Mason Clinic, Seattle, Washington; C. F. McKiel, Rush University, Chicago, Illinois; P. W. Nadig, San Antonio, Texas; R. A. Roth, Lahey Clinic Medical Center, Burlington, Massachusetts; J. Coleman, New York Hospital-Cornell Medical Center, New York, New York, and R. Witherington, Medical College of Georgia, Augusta, Georgia. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "1989",
doi = "10.1016/S0022-5347(17)40731-2",
language = "English (US)",
volume = "141",
pages = "243--247",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",
}